Global Erythropoietin Stimulating Agents Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 101

Published Date: 09 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.

According to our (Global Info Research) latest study, the global Erythropoietin Stimulating Agents market size was valued at USD 6111 million in 2022 and is forecast to a readjusted size of USD 6663.4 million by 2029 with a CAGR of 1.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Erythropoietin Stimulating Agents market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Erythropoietin Stimulating Agents market size and forecasts, in consumption value ($ Million), 2018-2029
Global Erythropoietin Stimulating Agents market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Erythropoietin Stimulating Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Erythropoietin Stimulating Agents market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Erythropoietin Stimulating Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Erythropoietin Stimulating Agents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Amgen, BioSidus, Biocon and Celltrion, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Erythropoietin Stimulating Agents market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Epoetin Alfa
    Epoetin Beta
    Darbepoetin Alfa
    Others

Market segment by Application
    Hospitals
    Clinics
    Others

Market segment by players, this report covers
    Pfizer
    Amgen
    BioSidus
    Biocon
    Celltrion
    Roche
    Intas Pharmaceuticals
    Johnson and Johnson
    Teva Pharmaceutical Industries
    Thermo Fisher Scientific

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Erythropoietin Stimulating Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Erythropoietin Stimulating Agents, with revenue, gross margin and global market share of Erythropoietin Stimulating Agents from 2018 to 2023.
Chapter 3, the Erythropoietin Stimulating Agents competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Erythropoietin Stimulating Agents market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Erythropoietin Stimulating Agents.
Chapter 13, to describe Erythropoietin Stimulating Agents research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Erythropoietin Stimulating Agents
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Erythropoietin Stimulating Agents by Type
        1.3.1 Overview: Global Erythropoietin Stimulating Agents Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Erythropoietin Stimulating Agents Consumption Value Market Share by Type in 2022
        1.3.3 Epoetin Alfa
        1.3.4 Epoetin Beta
        1.3.5 Darbepoetin Alfa
        1.3.6 Others
    1.4 Global Erythropoietin Stimulating Agents Market by Application
        1.4.1 Overview: Global Erythropoietin Stimulating Agents Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Clinics
        1.4.4 Others
    1.5 Global Erythropoietin Stimulating Agents Market Size & Forecast
    1.6 Global Erythropoietin Stimulating Agents Market Size and Forecast by Region
        1.6.1 Global Erythropoietin Stimulating Agents Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Erythropoietin Stimulating Agents Market Size by Region, (2018-2029)
        1.6.3 North America Erythropoietin Stimulating Agents Market Size and Prospect (2018-2029)
        1.6.4 Europe Erythropoietin Stimulating Agents Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Erythropoietin Stimulating Agents Market Size and Prospect (2018-2029)
        1.6.6 South America Erythropoietin Stimulating Agents Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Erythropoietin Stimulating Agents Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Erythropoietin Stimulating Agents Product and Solutions
        2.1.4 Pfizer Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Pfizer Recent Developments and Future Plans
    2.2 Amgen
        2.2.1 Amgen Details
        2.2.2 Amgen Major Business
        2.2.3 Amgen Erythropoietin Stimulating Agents Product and Solutions
        2.2.4 Amgen Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Amgen Recent Developments and Future Plans
    2.3 BioSidus
        2.3.1 BioSidus Details
        2.3.2 BioSidus Major Business
        2.3.3 BioSidus Erythropoietin Stimulating Agents Product and Solutions
        2.3.4 BioSidus Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 BioSidus Recent Developments and Future Plans
    2.4 Biocon
        2.4.1 Biocon Details
        2.4.2 Biocon Major Business
        2.4.3 Biocon Erythropoietin Stimulating Agents Product and Solutions
        2.4.4 Biocon Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Biocon Recent Developments and Future Plans
    2.5 Celltrion
        2.5.1 Celltrion Details
        2.5.2 Celltrion Major Business
        2.5.3 Celltrion Erythropoietin Stimulating Agents Product and Solutions
        2.5.4 Celltrion Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Celltrion Recent Developments and Future Plans
    2.6 Roche
        2.6.1 Roche Details
        2.6.2 Roche Major Business
        2.6.3 Roche Erythropoietin Stimulating Agents Product and Solutions
        2.6.4 Roche Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Roche Recent Developments and Future Plans
    2.7 Intas Pharmaceuticals
        2.7.1 Intas Pharmaceuticals Details
        2.7.2 Intas Pharmaceuticals Major Business
        2.7.3 Intas Pharmaceuticals Erythropoietin Stimulating Agents Product and Solutions
        2.7.4 Intas Pharmaceuticals Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Intas Pharmaceuticals Recent Developments and Future Plans
    2.8 Johnson and Johnson
        2.8.1 Johnson and Johnson Details
        2.8.2 Johnson and Johnson Major Business
        2.8.3 Johnson and Johnson Erythropoietin Stimulating Agents Product and Solutions
        2.8.4 Johnson and Johnson Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Johnson and Johnson Recent Developments and Future Plans
    2.9 Teva Pharmaceutical Industries
        2.9.1 Teva Pharmaceutical Industries Details
        2.9.2 Teva Pharmaceutical Industries Major Business
        2.9.3 Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Product and Solutions
        2.9.4 Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
    2.10 Thermo Fisher Scientific
        2.10.1 Thermo Fisher Scientific Details
        2.10.2 Thermo Fisher Scientific Major Business
        2.10.3 Thermo Fisher Scientific Erythropoietin Stimulating Agents Product and Solutions
        2.10.4 Thermo Fisher Scientific Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Thermo Fisher Scientific Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Erythropoietin Stimulating Agents Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Erythropoietin Stimulating Agents by Company Revenue
        3.2.2 Top 3 Erythropoietin Stimulating Agents Players Market Share in 2022
        3.2.3 Top 6 Erythropoietin Stimulating Agents Players Market Share in 2022
    3.3 Erythropoietin Stimulating Agents Market: Overall Company Footprint Analysis
        3.3.1 Erythropoietin Stimulating Agents Market: Region Footprint
        3.3.2 Erythropoietin Stimulating Agents Market: Company Product Type Footprint
        3.3.3 Erythropoietin Stimulating Agents Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Erythropoietin Stimulating Agents Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Erythropoietin Stimulating Agents Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Erythropoietin Stimulating Agents Consumption Value Market Share by Application (2018-2023)
    5.2 Global Erythropoietin Stimulating Agents Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Erythropoietin Stimulating Agents Consumption Value by Type (2018-2029)
    6.2 North America Erythropoietin Stimulating Agents Consumption Value by Application (2018-2029)
    6.3 North America Erythropoietin Stimulating Agents Market Size by Country
        6.3.1 North America Erythropoietin Stimulating Agents Consumption Value by Country (2018-2029)
        6.3.2 United States Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        6.3.3 Canada Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        6.3.4 Mexico Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Erythropoietin Stimulating Agents Consumption Value by Type (2018-2029)
    7.2 Europe Erythropoietin Stimulating Agents Consumption Value by Application (2018-2029)
    7.3 Europe Erythropoietin Stimulating Agents Market Size by Country
        7.3.1 Europe Erythropoietin Stimulating Agents Consumption Value by Country (2018-2029)
        7.3.2 Germany Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        7.3.3 France Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        7.3.5 Russia Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        7.3.6 Italy Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Erythropoietin Stimulating Agents Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Erythropoietin Stimulating Agents Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Erythropoietin Stimulating Agents Market Size by Region
        8.3.1 Asia-Pacific Erythropoietin Stimulating Agents Consumption Value by Region (2018-2029)
        8.3.2 China Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        8.3.3 Japan Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        8.3.4 South Korea Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        8.3.5 India Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        8.3.7 Australia Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Erythropoietin Stimulating Agents Consumption Value by Type (2018-2029)
    9.2 South America Erythropoietin Stimulating Agents Consumption Value by Application (2018-2029)
    9.3 South America Erythropoietin Stimulating Agents Market Size by Country
        9.3.1 South America Erythropoietin Stimulating Agents Consumption Value by Country (2018-2029)
        9.3.2 Brazil Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        9.3.3 Argentina Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Erythropoietin Stimulating Agents Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Erythropoietin Stimulating Agents Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Erythropoietin Stimulating Agents Market Size by Country
        10.3.1 Middle East & Africa Erythropoietin Stimulating Agents Consumption Value by Country (2018-2029)
        10.3.2 Turkey Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)
        10.3.4 UAE Erythropoietin Stimulating Agents Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Erythropoietin Stimulating Agents Market Drivers
    11.2 Erythropoietin Stimulating Agents Market Restraints
    11.3 Erythropoietin Stimulating Agents Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Erythropoietin Stimulating Agents Industry Chain
    12.2 Erythropoietin Stimulating Agents Upstream Analysis
    12.3 Erythropoietin Stimulating Agents Midstream Analysis
    12.4 Erythropoietin Stimulating Agents Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Erythropoietin Stimulating Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Erythropoietin Stimulating Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Erythropoietin Stimulating Agents Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Erythropoietin Stimulating Agents Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Pfizer Company Information, Head Office, and Major Competitors
    Table 6. Pfizer Major Business
    Table 7. Pfizer Erythropoietin Stimulating Agents Product and Solutions
    Table 8. Pfizer Erythropoietin Stimulating Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Pfizer Recent Developments and Future Plans
    Table 10. Amgen Company Information, Head Office, and Major Competitors
    Table 11. Amgen Major Business
    Table 12. Amgen Erythropoietin Stimulating Agents Product and Solutions
    Table 13. Amgen Erythropoietin Stimulating Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Amgen Recent Developments and Future Plans
    Table 15. BioSidus Company Information, Head Office, and Major Competitors
    Table 16. BioSidus Major Business
    Table 17. BioSidus Erythropoietin Stimulating Agents Product and Solutions
    Table 18. BioSidus Erythropoietin Stimulating Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. BioSidus Recent Developments and Future Plans
    Table 20. Biocon Company Information, Head Office, and Major Competitors
    Table 21. Biocon Major Business
    Table 22. Biocon Erythropoietin Stimulating Agents Product and Solutions
    Table 23. Biocon Erythropoietin Stimulating Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Biocon Recent Developments and Future Plans
    Table 25. Celltrion Company Information, Head Office, and Major Competitors
    Table 26. Celltrion Major Business
    Table 27. Celltrion Erythropoietin Stimulating Agents Product and Solutions
    Table 28. Celltrion Erythropoietin Stimulating Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Celltrion Recent Developments and Future Plans
    Table 30. Roche Company Information, Head Office, and Major Competitors
    Table 31. Roche Major Business
    Table 32. Roche Erythropoietin Stimulating Agents Product and Solutions
    Table 33. Roche Erythropoietin Stimulating Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Roche Recent Developments and Future Plans
    Table 35. Intas Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 36. Intas Pharmaceuticals Major Business
    Table 37. Intas Pharmaceuticals Erythropoietin Stimulating Agents Product and Solutions
    Table 38. Intas Pharmaceuticals Erythropoietin Stimulating Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Intas Pharmaceuticals Recent Developments and Future Plans
    Table 40. Johnson and Johnson Company Information, Head Office, and Major Competitors
    Table 41. Johnson and Johnson Major Business
    Table 42. Johnson and Johnson Erythropoietin Stimulating Agents Product and Solutions
    Table 43. Johnson and Johnson Erythropoietin Stimulating Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Johnson and Johnson Recent Developments and Future Plans
    Table 45. Teva Pharmaceutical Industries Company Information, Head Office, and Major Competitors
    Table 46. Teva Pharmaceutical Industries Major Business
    Table 47. Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Product and Solutions
    Table 48. Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Teva Pharmaceutical Industries Recent Developments and Future Plans
    Table 50. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
    Table 51. Thermo Fisher Scientific Major Business
    Table 52. Thermo Fisher Scientific Erythropoietin Stimulating Agents Product and Solutions
    Table 53. Thermo Fisher Scientific Erythropoietin Stimulating Agents Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Thermo Fisher Scientific Recent Developments and Future Plans
    Table 55. Global Erythropoietin Stimulating Agents Revenue (USD Million) by Players (2018-2023)
    Table 56. Global Erythropoietin Stimulating Agents Revenue Share by Players (2018-2023)
    Table 57. Breakdown of Erythropoietin Stimulating Agents by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Erythropoietin Stimulating Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 59. Head Office of Key Erythropoietin Stimulating Agents Players
    Table 60. Erythropoietin Stimulating Agents Market: Company Product Type Footprint
    Table 61. Erythropoietin Stimulating Agents Market: Company Product Application Footprint
    Table 62. Erythropoietin Stimulating Agents New Market Entrants and Barriers to Market Entry
    Table 63. Erythropoietin Stimulating Agents Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Erythropoietin Stimulating Agents Consumption Value (USD Million) by Type (2018-2023)
    Table 65. Global Erythropoietin Stimulating Agents Consumption Value Share by Type (2018-2023)
    Table 66. Global Erythropoietin Stimulating Agents Consumption Value Forecast by Type (2024-2029)
    Table 67. Global Erythropoietin Stimulating Agents Consumption Value by Application (2018-2023)
    Table 68. Global Erythropoietin Stimulating Agents Consumption Value Forecast by Application (2024-2029)
    Table 69. North America Erythropoietin Stimulating Agents Consumption Value by Type (2018-2023) & (USD Million)
    Table 70. North America Erythropoietin Stimulating Agents Consumption Value by Type (2024-2029) & (USD Million)
    Table 71. North America Erythropoietin Stimulating Agents Consumption Value by Application (2018-2023) & (USD Million)
    Table 72. North America Erythropoietin Stimulating Agents Consumption Value by Application (2024-2029) & (USD Million)
    Table 73. North America Erythropoietin Stimulating Agents Consumption Value by Country (2018-2023) & (USD Million)
    Table 74. North America Erythropoietin Stimulating Agents Consumption Value by Country (2024-2029) & (USD Million)
    Table 75. Europe Erythropoietin Stimulating Agents Consumption Value by Type (2018-2023) & (USD Million)
    Table 76. Europe Erythropoietin Stimulating Agents Consumption Value by Type (2024-2029) & (USD Million)
    Table 77. Europe Erythropoietin Stimulating Agents Consumption Value by Application (2018-2023) & (USD Million)
    Table 78. Europe Erythropoietin Stimulating Agents Consumption Value by Application (2024-2029) & (USD Million)
    Table 79. Europe Erythropoietin Stimulating Agents Consumption Value by Country (2018-2023) & (USD Million)
    Table 80. Europe Erythropoietin Stimulating Agents Consumption Value by Country (2024-2029) & (USD Million)
    Table 81. Asia-Pacific Erythropoietin Stimulating Agents Consumption Value by Type (2018-2023) & (USD Million)
    Table 82. Asia-Pacific Erythropoietin Stimulating Agents Consumption Value by Type (2024-2029) & (USD Million)
    Table 83. Asia-Pacific Erythropoietin Stimulating Agents Consumption Value by Application (2018-2023) & (USD Million)
    Table 84. Asia-Pacific Erythropoietin Stimulating Agents Consumption Value by Application (2024-2029) & (USD Million)
    Table 85. Asia-Pacific Erythropoietin Stimulating Agents Consumption Value by Region (2018-2023) & (USD Million)
    Table 86. Asia-Pacific Erythropoietin Stimulating Agents Consumption Value by Region (2024-2029) & (USD Million)
    Table 87. South America Erythropoietin Stimulating Agents Consumption Value by Type (2018-2023) & (USD Million)
    Table 88. South America Erythropoietin Stimulating Agents Consumption Value by Type (2024-2029) & (USD Million)
    Table 89. South America Erythropoietin Stimulating Agents Consumption Value by Application (2018-2023) & (USD Million)
    Table 90. South America Erythropoietin Stimulating Agents Consumption Value by Application (2024-2029) & (USD Million)
    Table 91. South America Erythropoietin Stimulating Agents Consumption Value by Country (2018-2023) & (USD Million)
    Table 92. South America Erythropoietin Stimulating Agents Consumption Value by Country (2024-2029) & (USD Million)
    Table 93. Middle East & Africa Erythropoietin Stimulating Agents Consumption Value by Type (2018-2023) & (USD Million)
    Table 94. Middle East & Africa Erythropoietin Stimulating Agents Consumption Value by Type (2024-2029) & (USD Million)
    Table 95. Middle East & Africa Erythropoietin Stimulating Agents Consumption Value by Application (2018-2023) & (USD Million)
    Table 96. Middle East & Africa Erythropoietin Stimulating Agents Consumption Value by Application (2024-2029) & (USD Million)
    Table 97. Middle East & Africa Erythropoietin Stimulating Agents Consumption Value by Country (2018-2023) & (USD Million)
    Table 98. Middle East & Africa Erythropoietin Stimulating Agents Consumption Value by Country (2024-2029) & (USD Million)
    Table 99. Erythropoietin Stimulating Agents Raw Material
    Table 100. Key Suppliers of Erythropoietin Stimulating Agents Raw Materials
List of Figures
    Figure 1. Erythropoietin Stimulating Agents Picture
    Figure 2. Global Erythropoietin Stimulating Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Erythropoietin Stimulating Agents Consumption Value Market Share by Type in 2022
    Figure 4. Epoetin Alfa
    Figure 5. Epoetin Beta
    Figure 6. Darbepoetin Alfa
    Figure 7. Others
    Figure 8. Global Erythropoietin Stimulating Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Erythropoietin Stimulating Agents Consumption Value Market Share by Application in 2022
    Figure 10. Hospitals Picture
    Figure 11. Clinics Picture
    Figure 12. Others Picture
    Figure 13. Global Erythropoietin Stimulating Agents Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Erythropoietin Stimulating Agents Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market Erythropoietin Stimulating Agents Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global Erythropoietin Stimulating Agents Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global Erythropoietin Stimulating Agents Consumption Value Market Share by Region in 2022
    Figure 18. North America Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global Erythropoietin Stimulating Agents Revenue Share by Players in 2022
    Figure 24. Erythropoietin Stimulating Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players Erythropoietin Stimulating Agents Market Share in 2022
    Figure 26. Global Top 6 Players Erythropoietin Stimulating Agents Market Share in 2022
    Figure 27. Global Erythropoietin Stimulating Agents Consumption Value Share by Type (2018-2023)
    Figure 28. Global Erythropoietin Stimulating Agents Market Share Forecast by Type (2024-2029)
    Figure 29. Global Erythropoietin Stimulating Agents Consumption Value Share by Application (2018-2023)
    Figure 30. Global Erythropoietin Stimulating Agents Market Share Forecast by Application (2024-2029)
    Figure 31. North America Erythropoietin Stimulating Agents Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America Erythropoietin Stimulating Agents Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America Erythropoietin Stimulating Agents Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe Erythropoietin Stimulating Agents Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe Erythropoietin Stimulating Agents Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe Erythropoietin Stimulating Agents Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 41. France Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific Erythropoietin Stimulating Agents Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific Erythropoietin Stimulating Agents Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific Erythropoietin Stimulating Agents Consumption Value Market Share by Region (2018-2029)
    Figure 48. China Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 51. India Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America Erythropoietin Stimulating Agents Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America Erythropoietin Stimulating Agents Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America Erythropoietin Stimulating Agents Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa Erythropoietin Stimulating Agents Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa Erythropoietin Stimulating Agents Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa Erythropoietin Stimulating Agents Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 65. Erythropoietin Stimulating Agents Market Drivers
    Figure 66. Erythropoietin Stimulating Agents Market Restraints
    Figure 67. Erythropoietin Stimulating Agents Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Erythropoietin Stimulating Agents in 2022
    Figure 70. Manufacturing Process Analysis of Erythropoietin Stimulating Agents
    Figure 71. Erythropoietin Stimulating Agents Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer
Amgen
BioSidus
Biocon
Celltrion
Roche
Intas Pharmaceuticals
Johnson and Johnson
Teva Pharmaceutical Industries
Thermo Fisher Scientific

Related Reports

Global Erythropoietin Stimulating Agents Supply, Demand and Key Producers, 2023-2029

Global Erythropoietin Stimulating Agents Supply, Demand and Key Producers, 2023-2029

date 16 Feb 2023

date Medical Care

Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.

Global Erythropoietin Stimulating Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Erythropoietin Stimulating Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Erythropoietin Stimulating Agents market size was valued at USD 9197.8 million in 2023 and is forecast to a readjusted size of USD 12120 million by 2030 with a CAGR of 4.0% during review period.

Product Tags

Erythropoietin Stimulating Agents

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>